首页 > 最新文献

Journal of Investigative Dermatology最新文献

英文 中文
056 Translational application of IL-37-expressing Treg cells in inflammation and immunity 056 表达 IL-37 的 Treg 细胞在炎症和免疫中的转化应用
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.06.072
D.G. Osborne , M. Nakayama , J. Domenico , C.A. Dinarello , M. Fujita
{"title":"056 Translational application of IL-37-expressing Treg cells in inflammation and immunity","authors":"D.G. Osborne , M. Nakayama , J. Domenico , C.A. Dinarello , M. Fujita","doi":"10.1016/j.jid.2024.06.072","DOIUrl":"10.1016/j.jid.2024.06.072","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Page S10"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141959512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
012 ANB032, an investigational BTLA agonist monoclonal antibody, reduced T cell proliferation, inflammatory cytokine secretion, and prevented graft-versus-host disease (GvHD) in a mouse model 012 ANB032 是一种正在研究的 BTLA 激动剂单克隆抗体,可在小鼠模型中减少 T 细胞增殖、炎性细胞因子分泌并预防移植物抗宿主疾病(GvHD)。
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.06.028
E. Hare, M. Hsu, C. Schendel, C. Haines, P. Soroosh, S. Parmley, P. Lizzul, M. Dahl
{"title":"012 ANB032, an investigational BTLA agonist monoclonal antibody, reduced T cell proliferation, inflammatory cytokine secretion, and prevented graft-versus-host disease (GvHD) in a mouse model","authors":"E. Hare, M. Hsu, C. Schendel, C. Haines, P. Soroosh, S. Parmley, P. Lizzul, M. Dahl","doi":"10.1016/j.jid.2024.06.028","DOIUrl":"10.1016/j.jid.2024.06.028","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Page S2"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141959890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
013 Langerhans cells derived from monocytes drive the progression of psoriasis by promoting the local accumulation of inflammation through IRF8 013 源自单核细胞的朗格汉斯细胞通过 IRF8 促进局部炎症积聚,从而推动银屑病的发展
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.06.029
Z. Cai , J. Lan , S. Yan , Y. Xia , B. Jiang , J. Li , J. Tao
{"title":"013 Langerhans cells derived from monocytes drive the progression of psoriasis by promoting the local accumulation of inflammation through IRF8","authors":"Z. Cai , J. Lan , S. Yan , Y. Xia , B. Jiang , J. Li , J. Tao","doi":"10.1016/j.jid.2024.06.029","DOIUrl":"10.1016/j.jid.2024.06.029","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Page S3"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141959891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
044 Granzyme K elicits a new pathway of complement activation 044 Granzyme K引发补体激活的新途径
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.06.060
C. Donado , A. Jonsson , E. Theisen , M. Brenner
{"title":"044 Granzyme K elicits a new pathway of complement activation","authors":"C. Donado , A. Jonsson , E. Theisen , M. Brenner","doi":"10.1016/j.jid.2024.06.060","DOIUrl":"10.1016/j.jid.2024.06.060","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Page S8"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141959986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
060 Lichenoid drug reaction and pyoderma gangrenosum induced by pembrolizumab therapy: A case report and review of literature 060 由彭博利珠单抗治疗诱发的苔藓样药物反应和脓皮病:病例报告和文献综述
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.06.076
D. Badin , K. Bradley , A. Moore , J. Karch , I. Salem , B. Simmons
{"title":"060 Lichenoid drug reaction and pyoderma gangrenosum induced by pembrolizumab therapy: A case report and review of literature","authors":"D. Badin , K. Bradley , A. Moore , J. Karch , I. Salem , B. Simmons","doi":"10.1016/j.jid.2024.06.076","DOIUrl":"10.1016/j.jid.2024.06.076","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Page S10"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141960226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basophils Play a Protective Role in the Recovery of Skin Barrier Function from Mechanical Injury in Mice 嗜碱性粒细胞对小鼠机械损伤后皮肤屏障功能的恢复起到保护作用。
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2023.12.024

Physical trauma disrupts skin barrier function. How the skin barrier recovers is not fully understood. We evaluated in mice the mechanism of skin barrier recovery after mechanical injury inflicted by tape stripping. Tape stripping disrupted skin barrier function as evidenced by increased transepidermal water loss. We show that tape stripping induces IL-1–, IL-23–, and TCRγδ+-dependent upregulation of cutaneous Il17a and Il22 expression. We demonstrate that IL-17A and IL-22 induce epidermal hyperplasia, promote neutrophil recruitment, and delay skin barrier function recovery. Neutrophil depletion improved the recovery of skin barrier function and decreased epidermal hyperplasia. Single-cell RNA sequencing and flow cytometry analysis of skin cells revealed basophil infiltration into tape-stripped skin. Basophil depletion upregulated Il17a expression, increased neutrophil infiltration, and delayed skin barrier recovery. Comparative analysis of genes differentially expressed in tape-stripped skin of basophil-depleted mice and Il17a−/− mice indicated that basophils counteract the effects of IL-17A on the expression of epidermal and lipid metabolism genes important for skin barrier integrity. Our results demonstrate that basophils play a protective role by downregulating Il17a expression after mechanical skin injury, thereby counteracting the adverse effect of IL-17A on skin barrier function recovery, and suggest interventions to accelerate this recovery.

物理创伤会破坏皮肤屏障功能。皮肤屏障如何恢复尚不完全清楚。我们在小鼠身上评估了胶带剥离造成机械损伤后皮肤屏障的恢复机制。胶带剥离破坏了皮肤屏障功能,表现为经表皮失水增加。我们发现,剥离胶带会诱导 IL-1、IL-23 和 TCRγδ+ 依赖性上调皮肤 Il17a 和 Il22 的表达。我们证明,IL-17A 和 IL-22 可诱导表皮增生、促进中性粒细胞募集并延迟皮肤屏障功能的恢复。皮肤细胞的 scRNAseq 和流式细胞术分析表明,嗜碱性粒细胞浸润了胶带剥离的皮肤。嗜碱性粒细胞耗竭会上调Il17a的表达、增加中性粒细胞浸润并延迟皮肤屏障的恢复。对嗜碱性粒细胞耗竭小鼠和Il17a-/-小鼠胶带剥离皮肤中差异表达基因的比较分析表明,嗜碱性粒细胞能抵消IL-17A对表皮和脂质代谢基因表达的影响,这些基因对皮肤屏障的完整性非常重要。我们的研究结果表明,嗜碱性粒细胞在皮肤机械损伤后通过下调Il17a的表达发挥了保护作用,从而抵消了IL-17A对皮肤屏障功能恢复的不利影响,并提出了加快皮肤屏障功能恢复的新型干预措施。
{"title":"Basophils Play a Protective Role in the Recovery of Skin Barrier Function from Mechanical Injury in Mice","authors":"","doi":"10.1016/j.jid.2023.12.024","DOIUrl":"10.1016/j.jid.2023.12.024","url":null,"abstract":"<div><p>Physical trauma disrupts skin barrier function. How the skin barrier recovers is not fully understood. We evaluated in mice the mechanism of skin barrier recovery after mechanical injury inflicted by tape stripping. Tape stripping disrupted skin barrier function as evidenced by increased transepidermal water loss. We show that tape stripping induces IL-1–, IL-23–, and TCRγδ<sup>+</sup>-dependent upregulation of cutaneous <em>Il17a</em> and <em>Il22</em> expression. We demonstrate that IL-17A and IL-22 induce epidermal hyperplasia, promote neutrophil recruitment, and delay skin barrier function recovery. Neutrophil depletion improved the recovery of skin barrier function and decreased epidermal hyperplasia. Single-cell RNA sequencing and flow cytometry analysis of skin cells revealed basophil infiltration into tape-stripped skin. Basophil depletion upregulated <em>Il17a</em> expression, increased neutrophil infiltration, and delayed skin barrier recovery. Comparative analysis of genes differentially expressed in tape-stripped skin of basophil-depleted mice and <em>Il17a</em><sup><em>−/−</em></sup> mice indicated that basophils counteract the effects of IL-17A on the expression of epidermal and lipid metabolism genes important for skin barrier integrity. Our results demonstrate that basophils play a protective role by downregulating <em>Il17a</em> expression after mechanical skin injury, thereby counteracting the adverse effect of IL-17A on skin barrier function recovery, and suggest interventions to accelerate this recovery.</p></div>","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Pages 1784-1797.e4"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139577195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Matrix Metalloproteinase 9 Plays a Crucial Role in Inflammation and Itch in Allergic Contact Dermatitis by Regulating Toll-Like Receptor 2/1 Signaling MMP9 通过调节 TLR2/TLR1 信号在过敏性接触性皮炎的炎症和瘙痒中发挥关键作用
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.01.013
{"title":"Matrix Metalloproteinase 9 Plays a Crucial Role in Inflammation and Itch in Allergic Contact Dermatitis by Regulating Toll-Like Receptor 2/1 Signaling","authors":"","doi":"10.1016/j.jid.2024.01.013","DOIUrl":"10.1016/j.jid.2024.01.013","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Pages 1893-1897.e6"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0022202X24000848/pdfft?md5=c26c31650f1461be8284355e13d63460&pid=1-s2.0-S0022202X24000848-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139587416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study Rilzabrutinib治疗丘疹性荨麻疹的有效性和安全性:PEGASUS 3期随机研究》。
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.02.023

Trial design

Pemphigus is a rare but life-threatening autoimmune disease requiring long-term treatment that minimizes corticosteroid (CS) exposure while providing consistent disease control. The phase 2 pemphigus study of oral, reversible, covalent Bruton tyrosine kinase inhibitor rilzabrutinib demonstrated rapid and sustained efficacy with well-tolerated safety.

Methods

Adults (aged 18–80 years) were randomized 1:1 to 400 mg rilzabrutinib (n = 65) or placebo (n = 66) twice daily (with CS ≤ 0.5 mg/kg/d) for 37 weeks in the phase 3 PEGASUS study in moderate-to-severe pemphigus vulgaris/pemphigus foliaceus.

Results

The primary endpoint of complete remission from week 29 to week 37 with the amended endpoint CS dose ≤10 mg/d was not significant for 13 of 54 (24%) rilzabrutinib versus 10 of 55 (18%) placebo patients with PV (P = .45). Secondary endpoints showed numerical but nonsignificant improvements with rilzabrutinib (vs placebo) in reduced CS use, prolonged complete remission duration, and faster time to first complete remission.

Conclusions

Overall, rilzabrutinib was well-tolerated, with similar adverse events reported in both groups. Using minimal CS dose ≤10 mg/d and excluding remote observations, the primary efficacy endpoint was not met. However, results from a prespecified sensitivity analysis using CS dose ≤5 mg/d, considering all observations, and including all patients support Bruton tyrosine kinase inhibition as a viable therapeutic approach for pemphigus.

试验设计:丘疹性荨麻疹是一种罕见但危及生命的自身免疫性疾病,需要长期治疗,以尽量减少皮质类固醇(CS)暴露,同时持续控制病情。口服、可逆、共价布鲁顿酪氨酸激酶(BTK)抑制剂利扎布鲁替尼的丘疹性荨麻疹二期研究显示了快速、持续的疗效和良好的耐受性:在针对中重度寻常型丘疹性荨麻疹/黄褐斑(PV/PF)的PEGASUS 3期研究中,成人(18-80岁)按1:1比例随机接受利扎鲁替尼400毫克(n=65)或安慰剂(n=66)治疗,每天两次(CS≤0.5毫克/千克/天),疗程37周:第29-37周完全缓解(CR)的主要终点(修正终点CS剂量≤10 mg/d)在13/54(24%)例利扎布鲁替尼患者与10/55(18%)例安慰剂患者之间无显著性差异(P=0.45)。次要终点显示,利扎布替尼(与安慰剂相比)在减少CS使用、延长CR持续时间和加快首次CR时间方面有数值上的改善,但无显著性:总体而言,两组患者对利扎鲁替尼的耐受性良好,不良反应相似。使用最小CS剂量≤10 mg/d并排除远程观察,主要疗效终点未达到。然而,使用CS剂量≤5毫克/天、考虑所有观察结果并纳入所有患者的预设敏感性分析结果支持将BTK抑制作为治疗丘疹性荨麻疹的一种可行方法。
{"title":"Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study","authors":"","doi":"10.1016/j.jid.2024.02.023","DOIUrl":"10.1016/j.jid.2024.02.023","url":null,"abstract":"<div><h3>Trial design</h3><p>Pemphigus is a rare but life-threatening autoimmune disease requiring long-term treatment that minimizes corticosteroid (CS) exposure while providing consistent disease control. The phase 2 pemphigus study of oral, reversible, covalent Bruton tyrosine kinase inhibitor rilzabrutinib demonstrated rapid and sustained efficacy with well-tolerated safety.</p></div><div><h3>Methods</h3><p>Adults (aged 18–80 years) were randomized 1:1 to 400 mg rilzabrutinib (n = 65) or placebo (n = 66) twice daily (with CS ≤ 0.5 mg/kg/d) for 37 weeks in the phase 3 PEGASUS study in moderate-to-severe pemphigus vulgaris/pemphigus foliaceus.</p></div><div><h3>Results</h3><p>The primary endpoint of complete remission from week 29 to week 37 with the amended endpoint CS dose ≤10 mg/d was not significant for 13 of 54 (24%) rilzabrutinib versus 10 of 55 (18%) placebo patients with PV (<em>P</em> = .45). Secondary endpoints showed numerical but nonsignificant improvements with rilzabrutinib (vs placebo) in reduced CS use, prolonged complete remission duration, and faster time to first complete remission.</p></div><div><h3>Conclusions</h3><p>Overall, rilzabrutinib was well-tolerated, with similar adverse events reported in both groups. Using minimal CS dose ≤10 mg/d and excluding remote observations, the primary efficacy endpoint was not met. However, results from a prespecified sensitivity analysis using CS dose ≤5 mg/d, considering all observations, and including all patients support Bruton tyrosine kinase inhibition as a viable therapeutic approach for pemphigus.</p></div>","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Pages 1762-1771.e6"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0022202X24001921/pdfft?md5=721ed5e81ffa79e91815731562ff4a5d&pid=1-s2.0-S0022202X24001921-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deletion of Pak1 in CD11c-Positive Cells Confers Resistance to Mouse Skin Carcinogenesis 在 CD11c 阳性细胞中缺失 Pak1 可增强小鼠皮肤癌的抵抗力
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.01.021
{"title":"Deletion of Pak1 in CD11c-Positive Cells Confers Resistance to Mouse Skin Carcinogenesis","authors":"","doi":"10.1016/j.jid.2024.01.021","DOIUrl":"10.1016/j.jid.2024.01.021","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Pages 1890-1893.e5"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139688624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice 006 外源性 IL-27 可促进免疫抑制性 T 细胞,防止 C3H/HeJ 小鼠发生斑秃
IF 5.7 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jid.2024.06.022
S.J. Connell , P. Kahl , Z. Zhu , S. Crotts , M. Lensing , X. Bai , A. Jabbari
{"title":"006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice","authors":"S.J. Connell ,&nbsp;P. Kahl ,&nbsp;Z. Zhu ,&nbsp;S. Crotts ,&nbsp;M. Lensing ,&nbsp;X. Bai ,&nbsp;A. Jabbari","doi":"10.1016/j.jid.2024.06.022","DOIUrl":"10.1016/j.jid.2024.06.022","url":null,"abstract":"","PeriodicalId":16311,"journal":{"name":"Journal of Investigative Dermatology","volume":"144 8","pages":"Page S1"},"PeriodicalIF":5.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141949650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Investigative Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1